The Expression of Resistin in Adipose Tissues of Patients with Polycystic Ovary Syndrome and Insulin Resistance

被引：0

作者：

初永丽 ^{[1
]}

崔青 ^{[1
]}

冯桂姣 ^{[1
]}

宋志云 ^{[1
]}

姜学强 ^{[1
]}

机构：

[1] Department of Obstetrics and Gynecology,Yantai Yuhuangding Hospital

来源：

Current Medical Science | 2009年 / 05期

关键词：

polycystic ovary syndrome; resistin; fasting plasma glucose; fasting insulin; insulin resis-tance;

D O I：

暂无

中图分类号：

R711.75 [卵巢疾病];

学科分类号：

100211 ;

摘要：

The relationship between the expression of resistin in polycystic ovary syndrome(PCOS) and insulin resistance was investigated.The plasma resistin concentrations in 35 patients with PCOS and 40 controls were measured by ELISA.Luteinizing hormone(LH),follicle-stimulating hormone(FSH),and fasting insulin(FIN) were tested by radioimmunoassay.Insulin resistance index(HOMA-IR) was calculated.Fasting plasma glucose(FPG) was determined by oxidase test.Western blot and reverse transcriptase PCR(RT-PCR) methods were used to detect the expression of resistin in adipose tissues.The levels of plasma resistin,LH,LH/FSH and FIN and HOMA-IR in patients with PCOS were significantly higher than those in control group(all P<0.05).Plasma resistin was correlated positively with FPG,FIN,HOMA-IR,LH and LH/FSH(r=0.56,0.60,0.65,0.48,and 0.42 respectively).Resistin protein and mRNA expression levels in patients with PCOS were significantly higher than those in normal tissues(all P<0.01).It was concluded that resistin might be involved in the pathogenesis of insulin resistance of PCOS.

引用

页码：642 / 645

页数：4

共 7 条

[1] Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels[J] . C. Otto,B. Otto,B. G?ke,A. F. H. Pfeiffer,M. Lehrke,M. Vogeser,J. Spranger,K. G. Parhofer.Journal of Endocrinological Investigation . 2006 (3)
[2] Circulating Resistin Levels Are Not Associated with Fat Redistribution, Insulin Resistance, or Metabolic Profile in Patients with the Highly Active Antiretroviral Therapy-Induced Metabolic Syndrome[J] . Diana Barb,Sanjivini G. Wadhwa,Juergen Kratzsch,Alina Gavrila,Jean L. Chan,Catherine J. Williams,Adolf W. Karchmer,Christos S. Mantzoros.The Journal of Clinical Endocrinology ＆ Metabolism . 2005 (9)
[3] Resistin, central obesity, and type 2 diabetes[J] . CL McTernan,PG McTernan,AL Harte,PL Levick,AH Barnett,S Kumar.The Lancet . 2002 (9300)
[4] Molecular progress in infertility: polycystic ovary syndrome[J] . Richard S Legro,Jerome F Strauss.Fertility and Sterility . 2002 (3)
[5] Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice
Sturrock, NDC
Lannon, B
Fay, TN
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 469 - 473
[6] Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels
Ling, C
Kindblom, J
Wennbo, H
Billig, H
[J]. FEBS LETTERS, 2001, 507 (02) : 147 - 150
[7] Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man[J] . D. R. Matthews,J. P. Hosker,A. S. Rudenski,B. A. Naylor,D. F. Treacher,R. C. Turner.Diabetologia . 1985 (7)

← 1 →